Stay updated on Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page
- Check4 days agoChange DetectedA sitewide banner announces NIH website updates and notes that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check17 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 on the error page. The study record remains inaccessible.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record details, indicating an access restriction or site issue rather than a content update.SummaryDifference19%

- Check45 days agoChange DetectedA new publication citation by Poddubnyy et al. on extramusculoskeletal manifestations in Upadacitinib-treated Psoriatic Arthritis or Axial Spondyloarthritis was added to the Publications section. This expands the study's referenced literature and highlights ongoing related research.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded an NIH grant/contract funding line to the study details and updated the page revision to v3.6.6 (removing the previous v3.6.5).SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.